MiMedx Group Inc (MDXG)
9.22
+0.16
(+1.77%)
USD |
NASDAQ |
Nov 21, 16:00
9.215
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Profit Margin (Quarterly): 9.63% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 9.63% |
| June 30, 2024 | 20.21% |
| March 31, 2024 | 10.93% |
| December 31, 2023 | 72.19% |
| September 30, 2023 | 10.44% |
| June 30, 2023 | 1.48% |
| March 31, 2023 | -6.95% |
| December 31, 2022 | 13.22% |
| September 30, 2022 | -12.45% |
| June 30, 2022 | -16.25% |
| March 31, 2022 | -17.81% |
| December 31, 2021 | 0.39% |
| September 30, 2021 | -3.71% |
| June 30, 2021 | -2.61% |
| March 31, 2021 | -13.98% |
| December 31, 2020 | -24.19% |
| September 30, 2020 | -30.20% |
| June 30, 2020 | -15.78% |
| March 31, 2020 | -7.81% |
| December 31, 2019 | -9.79% |
| September 30, 2019 | 13.93% |
| June 30, 2019 | -25.52% |
| March 31, 2019 | -19.94% |
| December 31, 2018 | -39.12% |
| September 30, 2018 | -0.20% |
| Date | Value |
|---|---|
| June 30, 2018 | 1.89% |
| March 31, 2018 | 5.49% |
| December 31, 2017 | 39.83% |
| September 30, 2017 | 20.64% |
| June 30, 2017 | 10.56% |
| March 31, 2017 | 5.96% |
| December 31, 2016 | -13.10% |
| September 30, 2016 | 5.15% |
| June 30, 2016 | 3.44% |
| March 31, 2016 | 2.24% |
| December 31, 2015 | 25.81% |
| September 30, 2015 | 13.37% |
| June 30, 2015 | 11.89% |
| March 31, 2015 | 10.03% |
| December 31, 2014 | 9.69% |
| September 30, 2014 | 11.04% |
| June 30, 2014 | -1.52% |
| March 31, 2014 | -4.71% |
| December 31, 2013 | -7.93% |
| September 30, 2013 | -1.91% |
| June 30, 2013 | -5.60% |
| March 31, 2013 | -14.02% |
| December 31, 2012 | -15.28% |
| September 30, 2012 | -53.05% |
| June 30, 2012 | -15.23% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-30.20%
Minimum
Sep 2020
72.19%
Maximum
Dec 2023
-1.15%
Average
-5.33%
Median
Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -10.57K% |
| IGC Pharma Inc | -416.7% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Protalix BioTherapeutics Inc | 18.02% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 75.27% |
| Return on Assets | 43.45% |
| Return on Invested Capital | 60.77% |
| Gross Profit Margin (Quarterly) | 81.77% |
| Operating Margin (Quarterly) | 13.63% |
| Return on Net Operating Assets | 72.27% |